Rosenblatt Lowers Arm Price Target to $180
- Rating
- Buy
- Target
- $180
- from $203 (−11%)
- Outcome
- Reached
- on April 22, 2026
Rosenblatt’s latest target on Arm is now $250 (Jul 31, 2026); the median of 13 firms is $255. Rosenblatt has reached 68% of its year-old targets (34 scored).

What the analyst said
Rosenblatt analyst Hans Mosesmann lowered the price target on Arm Holdings (NASDAQ: ARM) to $180.00 (from $203.00) while maintaining a Buy rating.
“Arm delivered record revenue in 4QF25 beating consensus. This includes record quarterly revenue for both Licensing and Royalties. An important metric, Annualized Contract Value (ACV), increased 15% Y/Y, above the long-term expectation for mid-to-high single digit percent growth.
Upside to revenue led to a Non-GAAP EPS beat helped by some OpEx delayed from 4Q to 1Q. 1QF26 revenue guidance is a slight miss to consensus at the midpoint. Management is accelerating investments into new technologies which put OpEx above consensus, leading to the Non-GAAP EPS guidance miss.
In our view, with the AI market changes accelerating and TAM expanding, Arm cannot sit on its laurels. Its customers are relying on technology advancements to address the market. During the quarter, smartphone royalties increased 30% Y/Y while smartphone units increased 2%.
Arm’s increasing content per phone is driven by v9 adoption. v9 was 30% of royalties, up from 25% previously. Helped by increasing adoption of Arm’s Complete Subsystem (CSS) strategy. Management does not expect tariffs to directly affect its business though indirectly customers or customers’ customers demand may be disrupted.
Given this, management did not provide full year guidance. We are adjusting our estimates downward to reflect a more cautious outlook and increased OpEx. Our revised 12-month price target is $180 (down from $203) based on 70x our FY27 Non-GAAP EPS.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
ARM trades at $152. The 13 analysts who set a target in the last 3 months range from $160 to $641, with a median of $255. This $180 target is 29% below the median.
Since the note ARM has moved +23% (from $124). The 12-month window closed on May 8, 2026.
Track record
This call✓ Target reached on April 22, 2026, 11 months after the note.
Firm track recordRosenblatt: 68% of its 34 targets at least a year old were reached within 12 months (#24 of 29 firms); on Arm, 1 of 2. Accuracy ranking →
Rosenblatt on Arm
Rosenblatt price targets on Arm
5 calls from February 6, 2025 to July 31, 2026. The target went from $225 to $250 (+11%). The rating stayed Buy.
- July 31, 2026Target cut from $270 (−7%)Buy$250
- May 7, 2026Target raised from $175 (+54%)Buy$270
- February 5, 2026Target cut from $180 (−3%)Buy$175
- May 8, 2025 This noteTarget cut from $225 (−20%)Buy$180
- February 6, 2025Earliest call shownBuy$225




